Finnrick - Ensuring a Safer and More Transparent Supply Chain
Shanghai ERP peptide Biotechnology

Shanghai ERP peptide Biotechnology

Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP agonist) from Shanghai ERP peptide Biotechnology between 7 Jan 2026 and 26 Feb 2026. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
Shanghai ERP peptide Biotechnology
Tirzepatide
Tested 6 Samples
Last test 26 Feb 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Shanghai ERP peptide Biotechnology

Samples are tested in commercial labs

Tests Count

6

Scores

AVG6.8MIN4.5MAX8.0

Last

26 Feb 2026

First

7 Jan 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityEndotoxinsBatch IDContainerTested AtSent By
26 Feb 2026View6.920mg21.7mg+8.5%99.90%
below LOQ
(no batch ID)No Label / Copper Crimp / Clear CapLab EPublic
26 Feb 2026View5.710mg9.35mg-6.5%99.10%
below LOQ
(no batch ID)No Label / Silver Crimp / Violet CapLab EPublic
10 Feb 2026View8.060mg60.9mg+1.5%99.90%n/a(no batch ID)No Label / Silver Crimp / Clear Red CapLab GPublic
22 Jan 2026View8.030mg31.1mg+3.7%99.90%n/a(no batch ID)No Label / Silver Crimp / Orange CapLab GPublic
15 Jan 2026View7.815mg15mg99.80%n/a(no batch ID)No Label / Silver Crimp / Red CapLab GPublic
7 Jan 2026View4.530mg36.3mg+21.0%99.70%n/a(no batch ID)No Label / Silver Crimp / Orange CapLab GPublic